Veterinary Medicines

Buscopan compositum injekció A.U.V.

Authorised
  • Hyoscine butylbromide
  • Metamizole sodium
Download as PDF

Product identification

Medicine name:
Buscopan compositum injekció A.U.V.
Active substance:
  • Hyoscine butylbromide
  • Metamizole sodium
Target species:
  • Cattle
  • Pig
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Hyoscine butylbromide
    0.40
    gram(s)
    /
    100.00
    millilitre(s)
  • Metamizole sodium
    50.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        15
        day
    • Dog
  • Intravenous use
    • Cattle
      • Meat and offal
        28
        day
    • Horse
      • Meat and offal
        9
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03DB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."